You are here

MS treatments 'could be boosted' by inexpensive treatment

MS treatments 'could be boosted' by inexpensive treatment
18th August 2009

A drug which is more commonly used as a treatment for hypertension may turn out to be an effective and cheap way of addressing multiple sclerosis (MS), it has been discovered.

Lawrence Steinman, the senior author of a new study carried out by Stanford University School of Medicine, asserted that with the right testing, lisinopril could be used to treat MS in the brains of humans in the same way it was able to reverse the disease's effects in mice.

Publishing his findings in Proceedings of the National Academy of Sciences, Dr Steinman made his assertions following the discovery of many links between the drug and the treatment of MS, before carrying out the tests.

He continued: "If multiple-sclerosis patients can be treated with lisinopril at something like one per cent of the price of treatment with Tysabri, then far more patients will receive adequate therapy, at a substantially lower cost to those paying for it."

Recently, the MS Society stood its ground regarding its stance on the government's green paper on social care reform, stating that it is currently running interviews with members before addressing the release.

Please click here for advice to help you find the right type of care.